[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2013160850A1 - Product packaging - Google Patents

Product packaging Download PDF

Info

Publication number
WO2013160850A1
WO2013160850A1 PCT/IB2013/053242 IB2013053242W WO2013160850A1 WO 2013160850 A1 WO2013160850 A1 WO 2013160850A1 IB 2013053242 W IB2013053242 W IB 2013053242W WO 2013160850 A1 WO2013160850 A1 WO 2013160850A1
Authority
WO
WIPO (PCT)
Prior art keywords
pills
product packaging
booklet
subset
blister pack
Prior art date
Application number
PCT/IB2013/053242
Other languages
French (fr)
Inventor
Warren Dennis
Original Assignee
Warren Dennis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warren Dennis filed Critical Warren Dennis
Publication of WO2013160850A1 publication Critical patent/WO2013160850A1/en
Priority to ZA2014/07669A priority Critical patent/ZA201407669B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D75/32Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D75/325Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil
    • B65D75/327Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil and forming several compartments

Definitions

  • This invention relates to a packaging for consumable products such as pills. BACKGROUND TO THE INVENTION
  • Products that are designed for human consumption at determinable time intervals are provided in numerous packaging formats. These products include pills in the form of tablets or capsules, and these are typically contained and presented in bottles with screw on lids or in boxes containing pills in blister packs.
  • a problem with bottled products is that only one type of pill can be contained in a single bottle. This means it is not possible using such a container to provide pills with differing contents. An example of pills that cannot practically be presented in such packaging is contraceptive pills.
  • a problem with blister pack type packaging is that it typically presents pills in rows and relies on the colour of pills, printing on the blister pack itself, and a separate inserted leaflet to instruct a consumer on which tablets to consume when.
  • Such packaging is often confusing and leaves people unsure of which tablets to take and when to take them.
  • the instruction pamphlet which is separate from the blister pack, is lost or discarded and that the blister pack is then used without the instructions readily available. This may lead to confusion, especially in the case of multiphase contraceptive pills that are not always consumed fully in each phase (such as when a woman wishes to delay the onset of one phase and skips a set of pills from one phase). It may also lead to damage to the foil of the blister pack itself, which could affect the efficacy of the pills.
  • pill means any preparation in the form of a tablet, capsule or the like which is intended to be consumed by a human or animal, whether for therapeutic or preventive effect.
  • a set of pills means pills with differing ingredients which are configured for consumption over predeterminable intervals according to specific time-varying requirements of the intended consumer thereof, and which include more than one subset of pills.
  • a subset of pills means a subset of pills forming part of set of pills, each pill of such subset having similar (but not necessarily completely identical ingredients) and which are intended for consumption during a predetermined period, for example a week of a month.
  • a product packaging for a set of pills comprising a booklet having a predetermined number of pages each of which is configured to contain a subset of pills, and preferably containing information relating to a subset of pills on a reverse side of a preceding page operatively for the information to be located adjacent the subset of pills when the booklet is opened at such subset of pills.
  • the booklet to include a front cover, and for the last page of the booklet to form a rear cover for the booklet.
  • each page to contain a sleeve within which a blister pack of subset of pills is receivable, with a side of the sleeve, preferably the topside, being open to slidably extract and receive the blister pack.
  • information on the reverse side of a preceding page to comprise instructions for consumption of the associated subset of pills, and further preferably for the blister pack to also include instructions, such as colour coding, for consumption of the associated subset of pills, including at least the sequence in which the pills have to be consumed.
  • each page of the booklet to contain a blister pack having a subset of pills for consumption over a period of one or two weeks, and further preferably for the pills to comprise any one or more of supplements, preferably hormone supplements, more preferably female hormonal supplements configured for specific ages and phases relating to the female hormonal cycle; alternatively contraceptives, preferably female contraceptives, and further alternatively a combination of female hormonal supplements and female contraceptives.
  • supplements preferably hormone supplements, more preferably female hormonal supplements configured for specific ages and phases relating to the female hormonal cycle
  • contraceptives preferably female contraceptives
  • the hormonal supplement to be configured to supplement the hormonal requirements of a female as a result of her menstrual cycle.
  • the subset of pills on the last page of the booklet to optionally contain more or less pills than each of the subsets of pills on the other pages, and optionally for a representation corresponding to the number of pills normally required for a female menstrual cycle length to be printed on the last blister pack or reverse side of the preceding page.
  • the pills to be presented in the blister pack in a circular pattern, alternatively any desired pattern.
  • the sleeve to include a central aperture shaped to expose the arrangement of the subset of pills within the blister pack when the booklet is opened at the specific page, further preferably for the aperture to be shaped complimentary to the pattern of the subset of pills in the blister pack, and most preferably for the aperture and the arrangement of the subset of pills to be circular.
  • a method of presenting a set of pills including providing a packaging as defined above with a blister pack of a subset of pills in each sleeve of the booklet which corresponds to a predetermined portion of a period of time, and preferably for the subset of pills in each sleeve to contain pills for one or two weeks out of multi-week cycle, more preferably a four week cycle, with the sequence of consumption of the subsets of pills determining their respective locations in the booklet.
  • a packaged set of pills which includes a set of pills with a plurality of subsets of pills packaged in a product packaging as defined above, and preferably for the packaged set of pills to comprise a set of female hormonal supplements configured to complement the supplementary requirements of a female human during the various phases of her hormonal cycle, comprising further preferably a set of hormonal supplements for one of five age groups for females including teenagers, adults with premenstrual stress, mature adults undergoing menopause, mature adults with severe menopausal symptoms, and senior adults post menopause.
  • a packaged set of pills which includes on each page a combination of a contraceptive and a hormonal supplement.
  • Figure 1 is a perspective view of a closed product packaging containing a set of pills according to a first embodiment of the invention
  • Figure 2 is a perspective view of the product packaging of Figure 1 with the front cover opened;
  • Figure 3 is a plan view of the packaging as shown in Figure 2;
  • Figure 4 is a bottom end view of the packaging as shown in Figure 2;
  • Figure 5 is a perspective view of a second embodiment of the product packaging with the front cover opened;
  • Figure 6 is a plan view of the packaging as shown in Figure 5.
  • Figure 7 is a bottom end view of the packaging as shown in Figure 5.
  • a first embodiment of a product packaging containing a set of pills according to the invention is shown in the drawings of Figure 1 to 4.
  • the packaging (1 ) is designed for a set of female hormonal supplements in the form of tablets (2).
  • the packaging (1 ) comprises a booklet (3) having four pages (4-7).
  • the booklet (3) includes a front cover (8) and the last page (7) forms the rear cover of the booklet (3).
  • Each page (4-7) comprises a double layer sleeve (9) which is open ended along its top (10).
  • Each sleeve (9) is designed to removably contain a blister pack of tablets (1 1 ).
  • the blister pack (1 1 ) may be inserted into the sleeve (9) through the open top (10).
  • Each sleeve (9) includes a central aperture (12) through which the tablets (2) in the blister pack (1 1 ) are visible when it is inserted into the sleeve (9). Since the sealed tablets (2) extend above the backing surface of the blister pack (1 1 ), the tablets (2) protrude through the aperture (12) when inserted into the sleeve (9), which assists in retaining the blister pack (1 1 ) within the sleeve (9).
  • Each blister pack (1 1 ) is slidably removable from its sleeve (9). This allows a tablet (2) to be removed from the blister pack (1 1 ) in the conventional manner by pressing it through its foil backing, and for the blister pack (1 1 ) to be replaced in the sleeve (9) afterwards, ready for its next use.
  • each sleeve (9) is designed to contain a subset of tablets in the form of the blister pack (1 1 ).
  • the blister pack (1 1 ) contains fourteen tablets.
  • the recommended dosage is one tablet (2) per day.
  • the booklet (3) thus contains fifty-six tablets on its four pages (4-7), which corresponds to one tablet (2) per day for two average female menstrual cycles of twenty-eight days each.
  • the blister pack (1 1 ) may also be provided with instructions for consumption of the tablets (2).
  • Each blister pack (1 1 ) may have appropriate numbering or signage (not shown) adjacent the pills to indicate the required sequence of consumption of tablets (2).
  • These and additional general information on the tablets (2) as well as each subset of tablets (2) may also be provided anywhere on the booklet (3).
  • the booklet (3) and blister pack (1 1 ) may also incorporate colour coding to facilitate the correct consumption of the tablets (2).
  • the blister pack (1 1 ) has a coloured backing at one or more tablets (2). This colour coding will correspond to instructions found on the cover (8) and reverse sides of the pages (4, 5 and 6) respectively.
  • the instructions will inform the user to consume the tablet located at a specific coloured backing at the required intervals, This will facilitate consumption of the correct first tablet (2) and the rest of the tablets (2) in the correct sequence.
  • the colour coding may also be used in combination with appropriate numbering and signage as discussed above.
  • the tablets (2) are configured to supplement the hormonal requirements of a woman as result of her menstrual cycle.
  • Booklets are provided in a number of variants, including a set for female teenagers (1 1 -19 years), a set for female adults (20-45 years), two sets for mature females (45-60), and a set for senior females (60+ years).
  • the set for teenager include supplements that provide assistance with a monthly hormonal cycle of a female teenager that typically struggles with hormone related skin issue, food cravings, pre-menstrual cramps and irregular periods.
  • the set for adult females include supplements that provide assistance with a monthly hormonal cycle of an adult female that is in the pregnancy phase of their life and require more folic acid, biotin, and zinc to support good reproduction, in addition to suffering from mood swings, breast tenderness, food cravings, bloating, insomnia and requiring breast care.
  • the first set for mature females include supplements that provide assistance with a monthly hormonal cycle of a mature female that is no longer menstruating and starting to experience symptoms such as mild to moderate hot flushes and night sweats, mood swings, anxiety, memory loss and requiring breast care.
  • the second set for mature females include supplements that provide assistance with a monthly hormonal cycle of a mature female that is no longer menstruating and starting to experience symptoms such as severe hot flushes and night sweats, mood swings, anxiety, memory loss and requiring breast care.
  • the set for senior females include supplements that provide assistance with a monthly hormonal cycle of a senior female that is starting to experience health issues relating to bone health and bone density, heart health, digestive health, breast care, memory function, blood sugar control, immunity and requires anti-aging supplements.
  • the five sets of pills described have different ingredients. It can further be appreciated that for each female described the requirements vary depending on her age and the time during her menstrual cycle.
  • the subsets of tablets (1 1 A-1 1 D) and their presentation on different pages (4-7) in the booklet (3) make it possible to provide each woman with a hormonal supplement that most accurately assists her during each specific phase of her menstrual cycle and her life.
  • the woman starts using the tablets (2) at the onset of her menstrual cycle, and consumes one tablet (2) per day.
  • a subset is finished she moves on to the next subset in the blister pack in the next page, until the booklet is empty of tablets.
  • her cycle is longer than twenty-eight days she waits until her next cycle starts before taking the first tablet of the next booklet. If her cycle is shorter than twenty-eight days, she starts using the next booklet when her next cycle starts and discards the unused tablet(s) from the booklet of her shortened cycle.
  • a second embodiment of a product packaging, in the form of a booklet (20), containing a set of pills according to the invention is shown in Figures 5 to 7.
  • the booklet (20) also contains four pages (21 ) and a cover (22) all of which are the same construction of the first embodiment.
  • This embodiment will be particularly useful when a booklet is required to contain the necessary tablets for only one normal menstrual cycle.
  • Each page contains seven tablets (23), with the four pages totalling twenty-eight tablets which is equal to a normal menstrual cycle.
  • the tablets provide the woman with a balanced intake of ingredients that are designed to most optimally supplement her requirements at every phase of her menstrual cycle. This avoids consuming supplements such as vitamins when they are not needed, and ensures that the correct amounts of such supplements are taken when they needed most.
  • supplements in addition to, or other than female hormonal supplements in the booklet. It can contain any type of pill that has to be taken in any type of cyclic manner. These include contraceptives, sport supplements, chronic medication, critical illness medication and the like.
  • a specific alternative to the first embodiment described above is to include both hormonal supplements and contraceptives in one booklet.
  • Each page will still include fourteen pills, of which seven will comprise hormonal supplements and seven will comprise contraceptives. These may be presented in pairs, ensuring that a woman takes a contraceptive and its complementary hormonal supplement at the same time. These can be marked on the foil of the blister pack to ensure there is no confusion. In this way, a woman is presented with a unique and accurate dosage of the correct amount of medication at the same time.
  • the booklet prefferably designed without a sleeve on each page, and for the tablets to be presented in a different manner on each page for use, for example by locating each tablet under a seal removably secured to the page.
  • the last page of the booklet may be provided with extra tablets. The idea of this will be that if a woman regularly has longer cycles she will consume more tablets during the last portion of her cycle. It is also possible for the last page to be provided with fewer tablets, effectively shortening the cycle over which the booklet will be used. This allows the booklet to be provided with a cycle length associated with it, and for woman to obtain a more tailored made booklet. For example, a 28-day Teen booklet may be provided as standard, but a 26, 27, 29 and 30 day Teen booklet may also be provided. The same could be done for any of the other formulations and age groups.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Composite Materials (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

The invention relates to a product packaging (1) for a set of pills that comprises a booklet with a number of pages (4) each of which contains a subset of pills. The invention also extends to a method of presenting a set of pills in such packaging.

Description

PRODUCT PACKAGING
FIELD OF THE INVENTION This invention relates to a packaging for consumable products such as pills. BACKGROUND TO THE INVENTION
Products that are designed for human consumption at determinable time intervals are provided in numerous packaging formats. These products include pills in the form of tablets or capsules, and these are typically contained and presented in bottles with screw on lids or in boxes containing pills in blister packs.
A problem with bottled products is that only one type of pill can be contained in a single bottle. This means it is not possible using such a container to provide pills with differing contents. An example of pills that cannot practically be presented in such packaging is contraceptive pills.
A problem with blister pack type packaging is that it typically presents pills in rows and relies on the colour of pills, printing on the blister pack itself, and a separate inserted leaflet to instruct a consumer on which tablets to consume when. Such packaging is often confusing and leaves people unsure of which tablets to take and when to take them. It also happens that the instruction pamphlet, which is separate from the blister pack, is lost or discarded and that the blister pack is then used without the instructions readily available. This may lead to confusion, especially in the case of multiphase contraceptive pills that are not always consumed fully in each phase (such as when a woman wishes to delay the onset of one phase and skips a set of pills from one phase). It may also lead to damage to the foil of the blister pack itself, which could affect the efficacy of the pills. The presently available product packaging is not conducive to presenting pills in a logical and systematic manner that is complimentary to cycles during which such pills may be consumed, and which provides adequate information relating to the pills in a format that is unlikely to be separated from the pills. In this specification the word "pill" means any preparation in the form of a tablet, capsule or the like which is intended to be consumed by a human or animal, whether for therapeutic or preventive effect. In this specification the phrase "a set of pills" means pills with differing ingredients which are configured for consumption over predeterminable intervals according to specific time-varying requirements of the intended consumer thereof, and which include more than one subset of pills. In this specification the phrase "a subset of pills" means a subset of pills forming part of set of pills, each pill of such subset having similar (but not necessarily completely identical ingredients) and which are intended for consumption during a predetermined period, for example a week of a month. OBJECT OF THE INVENTION
It is an object of the invention to provide a product packaging, a method of presenting a set of pills and a set of pills packaged according to the method that at least partly overcome the abovementioned problems.
SUMMARY OF THE INVENTION
In accordance with this invention there is provided a product packaging for a set of pills, the packaging comprising a booklet having a predetermined number of pages each of which is configured to contain a subset of pills, and preferably containing information relating to a subset of pills on a reverse side of a preceding page operatively for the information to be located adjacent the subset of pills when the booklet is opened at such subset of pills.
There is further provided for the booklet to include a front cover, and for the last page of the booklet to form a rear cover for the booklet.
There is further provided for each page to contain a sleeve within which a blister pack of subset of pills is receivable, with a side of the sleeve, preferably the topside, being open to slidably extract and receive the blister pack. There is further provided for the information on the reverse side of a preceding page to comprise instructions for consumption of the associated subset of pills, and further preferably for the blister pack to also include instructions, such as colour coding, for consumption of the associated subset of pills, including at least the sequence in which the pills have to be consumed.
There is further provided for each page of the booklet to contain a blister pack having a subset of pills for consumption over a period of one or two weeks, and further preferably for the pills to comprise any one or more of supplements, preferably hormone supplements, more preferably female hormonal supplements configured for specific ages and phases relating to the female hormonal cycle; alternatively contraceptives, preferably female contraceptives, and further alternatively a combination of female hormonal supplements and female contraceptives. There is still further provided for the hormonal supplement to be configured to supplement the hormonal requirements of a female as a result of her menstrual cycle.
According to a further feature of the invention there is provided for the subset of pills on the last page of the booklet to optionally contain more or less pills than each of the subsets of pills on the other pages, and optionally for a representation corresponding to the number of pills normally required for a female menstrual cycle length to be printed on the last blister pack or reverse side of the preceding page.
There is still further provided for the colours and ingredients of at least some of the subsets of pills to differ.
There is further provided for the pills to be presented in the blister pack in a circular pattern, alternatively any desired pattern. There is further provided for the sleeve to include a central aperture shaped to expose the arrangement of the subset of pills within the blister pack when the booklet is opened at the specific page, further preferably for the aperture to be shaped complimentary to the pattern of the subset of pills in the blister pack, and most preferably for the aperture and the arrangement of the subset of pills to be circular. According to a further feature of the invention there is provided a method of presenting a set of pills, the method including providing a packaging as defined above with a blister pack of a subset of pills in each sleeve of the booklet which corresponds to a predetermined portion of a period of time, and preferably for the subset of pills in each sleeve to contain pills for one or two weeks out of multi-week cycle, more preferably a four week cycle, with the sequence of consumption of the subsets of pills determining their respective locations in the booklet.
According to a still further feature there is provided a packaged set of pills which includes a set of pills with a plurality of subsets of pills packaged in a product packaging as defined above, and preferably for the packaged set of pills to comprise a set of female hormonal supplements configured to complement the supplementary requirements of a female human during the various phases of her hormonal cycle, comprising further preferably a set of hormonal supplements for one of five age groups for females including teenagers, adults with premenstrual stress, mature adults undergoing menopause, mature adults with severe menopausal symptoms, and senior adults post menopause.
According to a further feature of the invention there is provided a packaged set of pills which includes on each page a combination of a contraceptive and a hormonal supplement. These and other features of the invention are described in more detail below.
BRIEF DESCRIPTION OF THE DRAWINGS
Embodiments of the invention are described by way of example only and with reference to the accompanying drawings in which:
Figure 1 is a perspective view of a closed product packaging containing a set of pills according to a first embodiment of the invention;
Figure 2 is a perspective view of the product packaging of Figure 1 with the front cover opened;
Figure 3 is a plan view of the packaging as shown in Figure 2;
Figure 4 is a bottom end view of the packaging as shown in Figure 2;
Figure 5 is a perspective view of a second embodiment of the product packaging with the front cover opened;
Figure 6 is a plan view of the packaging as shown in Figure 5; and
Figure 7 is a bottom end view of the packaging as shown in Figure 5. DETAILED DESCRIPTION OF THE INVENTION
A first embodiment of a product packaging containing a set of pills according to the invention is shown in the drawings of Figure 1 to 4. The packaging (1 ) is designed for a set of female hormonal supplements in the form of tablets (2).
The packaging (1 ) comprises a booklet (3) having four pages (4-7). The booklet (3) includes a front cover (8) and the last page (7) forms the rear cover of the booklet (3).
Each page (4-7) comprises a double layer sleeve (9) which is open ended along its top (10). Each sleeve (9) is designed to removably contain a blister pack of tablets (1 1 ). The blister pack (1 1 ) may be inserted into the sleeve (9) through the open top (10). Each sleeve (9) includes a central aperture (12) through which the tablets (2) in the blister pack (1 1 ) are visible when it is inserted into the sleeve (9). Since the sealed tablets (2) extend above the backing surface of the blister pack (1 1 ), the tablets (2) protrude through the aperture (12) when inserted into the sleeve (9), which assists in retaining the blister pack (1 1 ) within the sleeve (9). Each blister pack (1 1 ) is slidably removable from its sleeve (9). This allows a tablet (2) to be removed from the blister pack (1 1 ) in the conventional manner by pressing it through its foil backing, and for the blister pack (1 1 ) to be replaced in the sleeve (9) afterwards, ready for its next use. In the embodiment shown each sleeve (9) is designed to contain a subset of tablets in the form of the blister pack (1 1 ). The blister pack (1 1 ) contains fourteen tablets. The recommended dosage is one tablet (2) per day. The booklet (3) thus contains fifty-six tablets on its four pages (4-7), which corresponds to one tablet (2) per day for two average female menstrual cycles of twenty-eight days each.
The blister pack (1 1 ) may also be provided with instructions for consumption of the tablets (2). Each blister pack (1 1 ) may have appropriate numbering or signage (not shown) adjacent the pills to indicate the required sequence of consumption of tablets (2). These and additional general information on the tablets (2) as well as each subset of tablets (2) may also be provided anywhere on the booklet (3). The booklet (3) and blister pack (1 1 ) may also incorporate colour coding to facilitate the correct consumption of the tablets (2). In this regard, the blister pack (1 1 ) has a coloured backing at one or more tablets (2). This colour coding will correspond to instructions found on the cover (8) and reverse sides of the pages (4, 5 and 6) respectively. The instructions will inform the user to consume the tablet located at a specific coloured backing at the required intervals, This will facilitate consumption of the correct first tablet (2) and the rest of the tablets (2) in the correct sequence. The colour coding may also be used in combination with appropriate numbering and signage as discussed above.
When all the tablets (2) from a subset of tablets in the blister pack (1 1 A) on one page (4) are finished (which will be after 14 days if consumed at the correct rate), the user turns to the next page (5) to use tablets (2) from the blister pack (1 1 B) therein.
The tablets (2) are configured to supplement the hormonal requirements of a woman as result of her menstrual cycle. Booklets are provided in a number of variants, including a set for female teenagers (1 1 -19 years), a set for female adults (20-45 years), two sets for mature females (45-60), and a set for senior females (60+ years).
The set for teenager include supplements that provide assistance with a monthly hormonal cycle of a female teenager that typically struggles with hormone related skin issue, food cravings, pre-menstrual cramps and irregular periods.
The set for adult females include supplements that provide assistance with a monthly hormonal cycle of an adult female that is in the pregnancy phase of their life and require more folic acid, biotin, and zinc to support good reproduction, in addition to suffering from mood swings, breast tenderness, food cravings, bloating, insomnia and requiring breast care.
The first set for mature females include supplements that provide assistance with a monthly hormonal cycle of a mature female that is no longer menstruating and starting to experience symptoms such as mild to moderate hot flushes and night sweats, mood swings, anxiety, memory loss and requiring breast care. The second set for mature females include supplements that provide assistance with a monthly hormonal cycle of a mature female that is no longer menstruating and starting to experience symptoms such as severe hot flushes and night sweats, mood swings, anxiety, memory loss and requiring breast care.
The set for senior females include supplements that provide assistance with a monthly hormonal cycle of a senior female that is starting to experience health issues relating to bone health and bone density, heart health, digestive health, breast care, memory function, blood sugar control, immunity and requires anti-aging supplements.
It can be appreciated from the above that the five sets of pills described have different ingredients. It can further be appreciated that for each female described the requirements vary depending on her age and the time during her menstrual cycle. The subsets of tablets (1 1 A-1 1 D) and their presentation on different pages (4-7) in the booklet (3) make it possible to provide each woman with a hormonal supplement that most accurately assists her during each specific phase of her menstrual cycle and her life.
The woman starts using the tablets (2) at the onset of her menstrual cycle, and consumes one tablet (2) per day. When a subset is finished she moves on to the next subset in the blister pack in the next page, until the booklet is empty of tablets. If her cycle is longer than twenty-eight days she waits until her next cycle starts before taking the first tablet of the next booklet. If her cycle is shorter than twenty-eight days, she starts using the next booklet when her next cycle starts and discards the unused tablet(s) from the booklet of her shortened cycle. If the woman suffers from cycles that vary greatly above and below twenty eight days, she may elect to keep the supplements from the last page when she has a shortened cycle and then later when she has a longer cycle use those retained tablets until her cycle ends, at which time she will start using a new booklet.
A second embodiment of a product packaging, in the form of a booklet (20), containing a set of pills according to the invention is shown in Figures 5 to 7. The booklet (20) also contains four pages (21 ) and a cover (22) all of which are the same construction of the first embodiment. This embodiment will be particularly useful when a booklet is required to contain the necessary tablets for only one normal menstrual cycle. Each page contains seven tablets (23), with the four pages totalling twenty-eight tablets which is equal to a normal menstrual cycle. The tablets provide the woman with a balanced intake of ingredients that are designed to most optimally supplement her requirements at every phase of her menstrual cycle. This avoids consuming supplements such as vitamins when they are not needed, and ensures that the correct amounts of such supplements are taken when they needed most. This is important since it is possible to consume too much of a specific supplement, for example some vitamins. In line with this, conventional supplements strikes a median in respect of their dosages, meaning it will overdose or under dose during some phase, and correctly dose during only some phases of a woman's menstrual cycle. It will be appreciated that the embodiments described above is given by way of example only and is not intended to limit the scope of the invention. It is example to alter aspects of the embodiments without departing from the essence of the invention.
It is for example possible to provide supplements, in addition to, or other than female hormonal supplements in the booklet. It can contain any type of pill that has to be taken in any type of cyclic manner. These include contraceptives, sport supplements, chronic medication, critical illness medication and the like.
A specific alternative to the first embodiment described above is to include both hormonal supplements and contraceptives in one booklet. Each page will still include fourteen pills, of which seven will comprise hormonal supplements and seven will comprise contraceptives. These may be presented in pairs, ensuring that a woman takes a contraceptive and its complementary hormonal supplement at the same time. These can be marked on the foil of the blister pack to ensure there is no confusion. In this way, a woman is presented with a unique and accurate dosage of the correct amount of medication at the same time.
It is also possible for the booklet to be designed without a sleeve on each page, and for the tablets to be presented in a different manner on each page for use, for example by locating each tablet under a seal removably secured to the page.
In respect of the shortening or lengthening of a cycle, this impacts consumption of tablets from the last subset of tablets, which is when the woman taking the tablets is menstruating. Thus, only tablets from the last page will be effected by such shortening or lengthening of a cycle. In an optional modification of the invention, the last page of the booklet may be provided with extra tablets. The idea of this will be that if a woman regularly has longer cycles she will consume more tablets during the last portion of her cycle. It is also possible for the last page to be provided with fewer tablets, effectively shortening the cycle over which the booklet will be used. This allows the booklet to be provided with a cycle length associated with it, and for woman to obtain a more tailored made booklet. For example, a 28-day Teen booklet may be provided as standard, but a 26, 27, 29 and 30 day Teen booklet may also be provided. The same could be done for any of the other formulations and age groups.

Claims

A product packaging for a set of pills, the packaging comprising a booklet having a predetermined number of pages each of which is configured to contain a subset of pills.
A product packaging for a set of pills as claimed in claim 2 wherein the pages contain information relating to the subset of pills on a reverse side of a preceding page, operatively for the information to be located adjacent the subset of pills when the booklet is opened at such subset of pills.
A product packaging for a set of pills as claimed in claim 3 wherein the information includes instructions for consumption of the pills.
A product packaging for a set of pills as claimed in claim 1 to 3 wherein the booklet includes a front cover, and a last page of the booklet forming a rear cover for the booklet.
A product packaging for a set of pills as claimed in any one of claims 1 to 4 wherein each page contains a sleeve within which a blister pack of subset of pills is receivable, with a side of the sleeve being open to slidably extract and receive the blister pack.
A product packaging for a set of pills as claimed in claim 5 wherein the topside is open to slidably extract and receive the blister pack.
A product packaging for a set of pills as claimed in any one of claims 5 or 6 wherein the blister pack includes instructions for consumption of the pills.
A product packaging for a set of pills as claimed in claim 7 wherein the instructions include colour coding.
A product packaging for a set of pills as claimed in any one of claims 1 to 8 wherein each page of the booklet contains a blister pack having a subset of pills for one or two weeks.
10. A product packaging for a set of pills as claimed in any one of claims 1 to 9 wherein the pills comprise supplements.
1 1 . A product packaging for a set of pills as claimed in claim 10 wherein the supplements are hormone supplements.
12. A product packaging for a set of pills as claimed in claim 1 1 wherein the hormone supplements are female hormonal supplements configured for specific ages and phases relating to the female hormonal cycle.
13. A product packaging for a set of pills as claimed in claim 1 1 or 12 wherein the hormonal supplements are configured to supplement the hormonal requirements of a female as a result of her menstrual cycle. 13. A product packaging for a set of pills as claimed in any one of claim 1 to 9 wherein the pills comprise contraceptives.
14. A product packaging for a set of pills as claimed in claims 13 wherein the contraceptives are female contraceptives.
15. A product packaging for a set of pills as claimed in claims 1 to 9 wherein the pills comprise any of the pills claimed in claims 9 to 14.
16. A product packaging for a set of pills as claimed in any one of the preceding claims wherein the subset of pills corresponding to the last blister pack of a cycle length contains more or less pills than each of the other subsets of pills in the cycle length.
17. A product packaging for a set of pills as claimed in claim 15 wherein a representation corresponding to the number of pills normally required for the cycle length is printed on the last blister pack or reverse side of the preceding page.
18. A product packaging for a set of pills as claimed in any one of the preceding claims wherein the colours and ingredients of at least some of the subsets of pills differ. 19. A product packaging for a set of pills as claimed in any one of claims 5 to 18 wherein the pills in the blister pack are presented in a pattern.
20. A product packaging for a set of pills as claimed in claim 19 wherein the pattern is circular.
21 . A product packaging for a set of pills as claimed in any one of claims 5 to 21 wherein the sleeve includes a central aperture shaped to expose the arrangement of the subset of pills within the blister pack when the booklet is opened at the specific page.
22. A product packaging for a set of pills as claimed in claim 21 wherein the aperture is shaped complimentary to the pattern of the subset of pills in the blister pack.
23. A packaged set of pills comprising a plurality of subsets of pills packaged in a product packaging as claimed in any one of claims 1 to 22.
24. A packaged set of pills as claimed in claim 23 in which the pills comprise a set of female hormonal supplements configured to complement the supplementary requirements of a female human during the various phases of her hormonal cycle.
25. A packaged set of pills as claimed in claim 24 in which the set of hormonal supplements comprise supplements for one of five age groups for females including teen females, adult females with premenstrual stress, mature females undergoing menopause, mature females with severe menopausal symptoms, and senior females post menopause.
26. A packaged set of pills as claimed in claim 22 which includes on each page a combination of a contraceptive and a hormonal supplement.
27. A method of presenting a set of pills, the method including providing a packaging as claimed in any one of the preceding claims with a blister pack of a subset of pills in each sleeve of the booklet which corresponds to a predetermined portion of a period of time.
28. A method of presenting a set of pills as claimed in claim 27 wherein the subset of pills in each sleeve contains pills for one or two weeks out of multi-week cycle with the sequence of consumption of the subsets of pills determining their respective locations in the booklet.
29. A method of presenting a set of pills as claimed in claim 28 wherein the cycle is a four-week cycle.
30. A method as claimed in claims 27 to 29 in which the period of time is represented by the sum of the portions of time represented by the sleeves in a booklet.
PCT/IB2013/053242 2012-04-25 2013-04-24 Product packaging WO2013160850A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA2014/07669A ZA201407669B (en) 2012-04-25 2014-10-22 Product packaging

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA201202828 2012-04-25
ZA2012/02828 2012-04-25

Publications (1)

Publication Number Publication Date
WO2013160850A1 true WO2013160850A1 (en) 2013-10-31

Family

ID=49482301

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2013/053242 WO2013160850A1 (en) 2012-04-25 2013-04-24 Product packaging

Country Status (2)

Country Link
WO (1) WO2013160850A1 (en)
ZA (1) ZA201407669B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2923966A1 (en) * 2014-03-28 2015-09-30 The Challenge Printing Company Packaging for pharmaceuticals including contraceptives
WO2017044568A1 (en) * 2015-09-08 2017-03-16 Accredo Health Group, Inc. Medication dispensing system
USD794470S1 (en) 2015-11-30 2017-08-15 Cryovac, Inc. Notebook with sheets for packaged products

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005068316A2 (en) * 2003-10-22 2005-07-28 Altana Pharma Ag Novel medicine pack
GB2411165A (en) * 2004-02-17 2005-08-24 Donald Aslett Medication dispensing pack
US20090139893A1 (en) * 2007-05-30 2009-06-04 Walgreen Co. Multi-Dose Blister Card Pillbook
US20090230013A1 (en) * 2008-03-17 2009-09-17 The Procter & Gamble Company User-Customizable Dosing System

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005068316A2 (en) * 2003-10-22 2005-07-28 Altana Pharma Ag Novel medicine pack
GB2411165A (en) * 2004-02-17 2005-08-24 Donald Aslett Medication dispensing pack
US20090139893A1 (en) * 2007-05-30 2009-06-04 Walgreen Co. Multi-Dose Blister Card Pillbook
US20090230013A1 (en) * 2008-03-17 2009-09-17 The Procter & Gamble Company User-Customizable Dosing System

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2923966A1 (en) * 2014-03-28 2015-09-30 The Challenge Printing Company Packaging for pharmaceuticals including contraceptives
WO2017044568A1 (en) * 2015-09-08 2017-03-16 Accredo Health Group, Inc. Medication dispensing system
US10265243B2 (en) 2015-09-08 2019-04-23 Accredo Health Group, Inc. Medication dispensing system
US10792220B2 (en) 2015-09-08 2020-10-06 Accredo Health Group, Inc. Medication dispensing system
USD794470S1 (en) 2015-11-30 2017-08-15 Cryovac, Inc. Notebook with sheets for packaged products

Also Published As

Publication number Publication date
ZA201407669B (en) 2015-09-30

Similar Documents

Publication Publication Date Title
ES2182729T3 (en) PACK OF STRIPS.
RU2483708C2 (en) Dosing device, adjusted to user's individual demands
JPS63500448A (en) Calendar Pill Dispenser
US7784616B2 (en) Dispenser for progestin used for acute maintenance treatment of DUB
JPS61500709A (en) Dated Pill Dispenser
JP2004500967A (en) Pharmaceutical product package for eradication treatment
US20120040018A1 (en) Ingestible Supplement for Women
US9782327B2 (en) Compliance pill tray system
KR102258043B1 (en) Increasing drug bioavailability in naltrexone therapy
KR20040037097A (en) Estrogen/gestagen combination preparation and application thereof
ES2338474T3 (en) ASSORTMENT OF PACKED PRODUCTS.
US10143627B2 (en) Compliance system
CN109152696B (en) Packaging device and packaging method for solid medicaments, storage and dispensing device and dispensing method for such medicaments
US5169001A (en) Medicament dispensing container
WO2013160850A1 (en) Product packaging
CN107074432A (en) Drug packages and dosage system
FR2611069A1 (en) DOSAGE CALENDAR
WO2012078317A1 (en) Methods and compositions useful for promoting sleep in animals
WO2001043571A1 (en) Dietary supplement system
Aubry et al. Pharmacotherapy of bipolar disorders
KR102042435B1 (en) Medicine packing device for distribution and storage of medicine powder
US20150034524A1 (en) Sealing sheet for closing a container-defining sheet reconfigurable between different dosage schedules
JP2006068175A (en) Medication label and vial
RU94457U1 (en) PACKING OF THE DAILY DOSAGE OF MEDICINES FOR ORAL USE FOR INTEGRATED MEDICINE THERAPY (OPTIONS) AND PACKING OF MEDICINES FOR ORAL USE FOR THE COURSE OF COMPLEX MEDICA
Braun The Poisons Standard and herbal medicines

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13781056

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13781056

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 13781056

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 12/01/2015)

122 Ep: pct application non-entry in european phase

Ref document number: 13781056

Country of ref document: EP

Kind code of ref document: A1